Literature DB >> 25012595

Gonadotrophin-independent precocious puberty associated with later diagnosis of testicular embryonal carcinoma.

Senthil Senniappan1, Dan Wood, Vaseem Hakeem, Sara Stoneham, Alex Freeman, Mehul Dattani.   

Abstract

BACKGROUND: Testicular tumours are very rare in children. Germ cell tumours (GCTs) account for the majority of testicular tumours in young people, and embryonal carcinomas are a common component of GCTs in adolescents. CASE
PRESENTATION: A 9.8-year-old boy presented with the development of pubic and facial hair over a period of 2 years. He had a growth spurt and examination revealed pubertal staging of G4 P4 A2 with a 6-mls testis on the right and a 4-mls testis on the left. Investigations revealed suppressed gonadotrophins, a testosterone concentration of 10.3 nmol/l and normal 17-hydroxyprogesterone and adrenal androgen levels. Tumour markers were negative. Following treatment with anastrazole, his height velocity slowed down. At the age of 13.7 years, his treatment was stopped. At the age of 14.8 years, he presented with a grossly enlarged right testis and elevated beta human chorionic gonadotrophin (>1,400 IU/l). He underwent right orchidectomy and histology revealed an embryonal carcinoma with no vascular invasion. Analysis of luteinizing hormone/choriogonadotrophin receptor revealed no mutation.
CONCLUSION: We present a case of testicular embryonal carcinoma in a boy who had presented 5 years before with features suggestive of gonadotrophin-independent precocious puberty.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25012595     DOI: 10.1159/000362187

Source DB:  PubMed          Journal:  Horm Res Paediatr        ISSN: 1663-2818            Impact factor:   2.852


  1 in total

1.  Precocious puberty related to Leydig cell testicular tumor: the diagnostic imaging keys.

Authors:  Téodor Grand; Anne-Laure Hermann; Maxime Gérard; Emmanuel Arama; Linda Ouerd; Nada Garrouche; Laurence Rocher
Journal:  Eur J Med Res       Date:  2022-05-12       Impact factor: 4.981

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.